TAILORED-CHIP Trial: Time-Dependent Antiplatelet Therapy in High-Risk PCI
Ahmed Bennis, Professor of Cardiology, shared a post on X:
”Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trial
TAILORED-CHIP trial is an investigator-initiated, multicentre, prospective randomised trial to evaluate the efficacy and safety of a time-dependent tailored antiplatelet therapy with an early (<6 months post-PCI) escalation (low-dose ticagrelor at 60 mg twice daily plus aspirin) and a late (>6 months post-PCI) de-escalation (clopidogrel monotherapy) in patients undergoing complex high-risk PCI as compared with standard DAPT (clopidogrel plus aspirin for 12 months).”
Read the full article here.
Title: Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trial
Authors: Hanbit Park, Do-Yoon Kang, Jung-Min Ahn, Sung-Cheol Yun, Kyoung-Ha Park, Se-Hun Kang, Jon Suh, Jang-Whan Bae, Sangwoo Park, Jang Hyun Cho, Jung-Won Suh, Bong-Ki Lee, Seung-Woon Rha, Hoyoun Won, Jae-Sik Jang, Moo Hyun Kim, Cheol Hyun Lee, Young Keun Ahn, Jun-Hyok Oh, Jae-Seok Bae, Chul Soo Park, Jaewoong Choi, Jin-Bae Lee, Se-Whan Lee, Sung-Ho Hur, Osung Kwon, Seung-Jung Park, Duk-Woo Park; on behalf of the TAILORED-CHIP trial investigators
Stay updated with Hemostasis Today.
-
Apr 19, 2026, 04:47Test Your Hematology Knowledge with ASH Questions and Answers – ASH
-
Apr 19, 2026, 04:26Priyanka Raheja: Happy World Haemophilia Day from The Royal London Haemophilia Centre
-
Apr 18, 2026, 18:55William Aird: Ferritin as a Probability Signal
-
Apr 18, 2026, 18:54Abdulla A. Damluji: OCEANIC-STROKE Trial Analysis and Its Clinical and Market Implications
-
Apr 18, 2026, 18:29Vasee Moorthy: Join WHO Clinical Trial Course Launch at Stand With Science 2026
-
Apr 18, 2026, 18:28Holly O’Byrne: Improving Hemorrhagic Shock Care With a Patient Centered System
-
Apr 18, 2026, 18:26Sthanu Subramanian: CVST as The ‘Great Masquerader’ with Normal Initial CT
-
Apr 18, 2026, 18:25Priyanka Raheja: Sharing the Final Analysis From the Roctavian Phase 1/2 Study
-
Apr 18, 2026, 18:23Jim Hoffman: Reversing Vascular Damage through NETosis Modulation and Efferocytosis Balance